In two large-scale trials, Compass Pathways' proprietary form of psilocybin improved people's depression symptoms better than controls.
Magic Mushroom Ingredient Passes Major Test, Paving Way for FDA Approval
Get alerts for these topics
GoKawiil
Tech News